Discovery Laboratories is a specialty biotechnology company engaged in the advancement of a new standard in respiratory critical care. The company’s novel proprietary KL4 surfactant technology creates a synthetic, peptide-containing surfactant that is similar in structure to pulmonary surfactant, and Discovery Labs is also developing its proprietary drug delivery technologies to facilitate efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. For more information, visit the company’s Web site: http://www.discoverylabs.com
Let us hear your thoughts below: